Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 9.60M | 18.3M | +8.66M (+90.3%) |
| Value | $19.8M | $48.2M | +$28.4M (+143.9%) |
New holders (7)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Zimmer Partners, LP | 2,109,704 | $5.57M | 0.11% |
| Sphera Funds Management Ltd. | 1,297,021 | $3.42M | 0.56% |
| Nantahala Capital Management, LLC | 600,000 | $1.58M | 0.16% |
| Alyeska Investment Group, L.P. | 500,000 | $1.32M | 0.01% |
| Bridgeway Capital Management, LLC | 33,400 | $88.2K | 0.00% |
| Dimensional Fund Advisors LP | 30,233 | $79.8K | 0.00% |
| Bank of America Corp | 6,818 | $18.0K | 0.00% |
Sold out (4)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 15,982 | $32.9K |
| Millennium Management LLC | 13,875 | $28.6K |
| Wells Fargo & Company | 189 | $389 |
| Group One Trading, L.P. | 22 | $45 |